Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.09 USD | -4.58% | -38.75% | -47.68% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
Financials (USD)
Sales 2024 * | 41.17M | Sales 2025 * | 13.66M | Capitalization | 630M |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -188M | EV / Sales 2024 * | 10.1 x |
Net cash position 2024 * | 215M | Net cash position 2025 * | 348M | EV / Sales 2025 * | 20.6 x |
P/E ratio 2024 * |
-4.89
x | P/E ratio 2025 * |
-3.55
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.46% |
Latest transcript on EyePoint Pharmaceuticals, Inc.
1 day | -4.58% | ||
1 week | -38.75% | ||
Current month | -31.31% | ||
1 month | -46.15% | ||
3 months | -59.31% | ||
6 months | +88.91% | ||
Current year | -47.68% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
George Elston
DFI | Director of Finance/CFO | 59 | 19-11-13 |
Said Saim
CTO | Chief Tech/Sci/R&D Officer | 66 | 19-06-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
Wendy DiCicco
BRD | Director/Board Member | 56 | 19-07-14 |
David Guyer
BRD | Director/Board Member | 64 | 19-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 11 M€ | -6.03% | - | |
0.37% | 4 M€ | -5.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 12.09 | -4.58% | 1,070,375 |
24-05-09 | 12.67 | +9.60% | 2,110,475 |
24-05-08 | 11.56 | -2.61% | 1,435,111 |
24-05-07 | 11.87 | +5.98% | 2,516,232 |
24-05-06 | 11.2 | -43.26% | 9,652,348 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.68% | 630M | |
+30.38% | 684B | |
+28.00% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.81% | 240B | |
+8.93% | 208B | |
-8.43% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- EYPT Stock